Provider Type Icon

DR. DANIEL RYAN SILBIGER D.O. NPI 1639490469


NPI Information

NPI: 1639490469
Provider Name: DR. DANIEL RYAN SILBIGER, D.O.
Classification: Internal Medicine - 207RH0003X
Entity Type: Individual

Specialization: Hematology & Oncology

PECOS Registration: Yes

Address:
9485 MENTOR AVE
SUITE 3
MENTOR, OH
ZIP 44060
Phone: (440) 205-5755
Get Directions

DR. Daniel Ryan Silbiger, D.O. is a hematology and oncology internal medicine in Mentor, OH with 14 years of experience. The provider is an internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered. DR. Daniel Ryan Silbiger, D.O. NPI is 1639490469. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: OHIO MEDICAL UNIVERSITY
Graduation Year:2010

The provider's business location address is:

9485 MENTOR AVE
SUITE 3
MENTOR, OH
ZIP 44060-597
Phone: (440) 205-5755
Fax: (440) 205-5713

The NPI 1639490469 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

  • Injection, fosaprepitant, 1 mg (HCPCS:J1453)
  • Injection, denosumab, 1 mg (HCPCS:J0897)
  • Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
  • Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
  • Injection of different drug or substance into a vein for therapy, diagnosis, or prevention (HCPCS:96375)
  • Insertion of needle into vein for collection of blood sample (HCPCS:36415)
  • Infusion of chemotherapy into a vein up to 1 hour (HCPCS:96413)
  • Injection beneath the skin or into muscle for therapy, diagnosis, or prevention (HCPCS:96372)
  • Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour (HCPCS:96365)
  • Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour (HCPCS:96367)
  • Administration of influenza virus vaccine (HCPCS:G0008)
  • Vaccine for influenza for injection into muscle (HCPCS:90662)

The enumeration date for this NPI number is 6/16/2010 and was last updated on 12/21/2020.


Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

No. Taxonomy Code Taxonomy Clasification Taxonomy Specialization License Number License State Primary
1207RH0003XInternal MedicineHematology & Oncology34.012156OHIOYes

What is NPI?

NPI stands for National Provider Identifier. The NPI is a 10-digit identification number that is completely unique. The NPI number by itself does not contain any identifiable information such as a provider’s speciality or location. The NPI is assigned to individuals or organizacions for their lifespan and it is independent of key provider information type updates like a change of practices, location or speciality.

This page was last updated on: 5/5/2024

All materials and services on this site are provided on an "as is" and "as available" basis without warranty of any kind. The NPI record is maintained by the National Plan & Provider Enumeration System (NPPES) and anyone may request this information and other NPPES health care provider data from HHS under The Freedom of Information Act (FOIA), Title 5 of the United States Code, section 552. To update the NPI records please contact the NPPES.